Brain-Computer Interface Innovation: Qiangnao Technology Reaches New Milestone with Historic Funding Achievement

DAOdreamer · 2026-01-12T19:24:40+00:00

Qiangnao Technology has raised about 20 billion yuan, making it a leader in the brain-computer interface sector, second only to Neuralink. Their focus includes developing neuro-controlled prosthetics for individuals with disabilities and enhancing human-machine integration for broader applications.

DAOdreamer

2026-01-12 19:24:40

Abstract generation in progress

The brain-computer interface sector has entered a transformative phase with Qiangnao Technology, one of Hangzhou’s leading tech innovators, successfully raising approximately 20 billion yuan. This substantial capital injection positions the company as a major force in the neural technology landscape, trailing only Elon Musk’s Neuralink in global funding scale within the brain-computer interface domain.

Redefining Human-Machine Integration Through Technology

The funding secured by Qiangnao Technology will catalyze breakthroughs in core neuro-technology architecture and enable scaled manufacturing capabilities. Company officials have outlined an ambitious roadmap focusing on two key dimensions: therapeutic applications and broader human enhancement.

On the medical front, the organization aims to restore functionality for individuals with physical disabilities through neuro-controlled prosthetic systems. Over the next half-decade to decade, they target supporting one million users in regaining autonomy and social participation. Beyond physical rehabilitation, the initiative encompasses neurological wellness—specifically addressing conditions including autism spectrum disorders, ADHD, Alzheimer’s disease progression, and sleep disorders affecting approximately ten million patients.

Expanding the Frontier of Brain-Computer Interface News

The longer-term vision extends beyond therapeutic interventions. Qiangnao Technology is pioneering a future where ordinary individuals leverage direct brain-interface connectivity to interact with their environment, fundamentally reconceptualizing the relationship between human cognition and machine responsiveness.

This funding round crystallizes the growing maturity of brain-computer interface technology. The capital deployment signals investor confidence in translating neurological research into scalable, real-world applications that address both unmet medical needs and emerging consumer possibilities.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.